Evogene Ltd. opens its new research and development facility in St. Louis, Missouri with an event highlighting “Driving Innovation for Agriculture”. The new facility is located at the Bio-Research and Development Growth (BRDG) Park, on the campus of The Donald Danforth Plant Science Center in St. Louis.
In addition to Ofer Haviv, Evogene’s president and CEO and James Presnail, the site head for Evogene, senior officials from Evogene and The Donald Danforth Plant Science Center participated in the opening celebration.
“We are pleased to be officially opening today our first R&D site located in the U.S, and in particular on the Campus of the Danforth Plant Science Center in St. Louis. This important expansion brings us geographically much closer to both world leading companies and research centers in our industry and to key target markets for our Company,” says Aviv.
“The site will initially be focused on our growing crop protection activities, primarily the Company’s ongoing insect control product programs and collaborations for controlling Coleopteran, Lepidopteran and Hemipteran – key crop damaging insects – and we expect to expand its activities in the future to additional Evogene areas of focus, in both crop enhancement and crop protection.”
